Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PA2G4P3 is classified as a pseudogene that is related to the functional PA2G4 gene. Pseudogenes like PA2G4P3 are genomic DNA sequences similar to known genes but generally non-functional, lacking protein-coding ability due to mutations or truncations. PA2G4P3 itself does not produce a functional protein, nor is it involved in known biological processes or implicated as a disease-related therapeutic target. Its aliases include HsT2542 and PA2G4L4. For structured molecular and therapeutic analyses, only the functional PA2G4 (proliferation-associated protein 2G4, also known as ErbB3-binding protein 1, EBP1) is relevant as a therapeutic target. PA2G4P3, by contrast, is not a protein, receptor, enzyme, nor transporter, and is not considered for drug targeting or disease biomarker use. It has no direct therapeutic, mechanistic, or biomarker roles. Its mention in target lists is usually incorrect, as only functional PA2G4 protein (not pseudogenes) is considered a valid molecular target. There is nothing known to interact with PA2G4P3, and it has no direct biological functions or disease roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proliferation-associated 2G4 pseudogene 3 (PA2G4P3).